<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>Science and Education Publishing</PublisherName>
<JournalTitle>International Journal of Hematological Disorders</JournalTitle>
<Volume>3</Volume>
<Issue>1</Issue>
<PubDate PubStatus="epublish">
<Year>2017</Year>
<Month>3</Month>
<Day>13</Day>
</PubDate>
</Journal>
<ArticleTitle>Idiopathic CD4+ Lymphocytopenia Associated with EvansĄŻ Syndrome: A Case Report</ArticleTitle>
<FirstPage>1</FirstPage>
<LastPage>2</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Ines</FirstName>
<LastName>Safra</LastName>
<Affiliation>University of Tunis El Manar, Medecine Tunis Faculty, HMC Laboratory, Pasteur Institute of Tunisia</Affiliation>
</Author>
<Author>
<FirstName>Imene</FirstName>
<LastName>Namouchi</LastName>
</Author>
<Author>
<FirstName>HMC</FirstName>
<LastName>Laboratory</LastName>
</Author>
<Author>
<FirstName>Salem</FirstName>
<LastName>Abbes</LastName>
</Author>
<Author>
<FirstName>Samia</FirstName>
<LastName>Mnif</LastName>
</Author>

</AuthorList>
<ArticleIdList>
<ArticleId IdType="pii">IJHD2017311</ArticleId>
<ArticleId IdType="doi">10.12691/ijhd-3-1-1</ArticleId>
</ArticleIdList>
<History>
<PubDate PubStatus="received">
<Year>2016</Year>
<Month>10</Month>
<Day>21</Day>
</PubDate>
<PubDate PubStatus="revised">
<Year>2017</Year>
<Month>2</Month>
<Day>1</Day>
</PubDate>
<PubDate PubStatus="accepted">
<Year>2017</Year>
<Month>3</Month>
<Day>11</Day>
</PubDate>
</History>
<Abstract>Idiopathic CD4+ lymphocytopenia (ICL) is a syndrome first defined in 1992 by the Centers for Disease Control and Prevention (CDCP) as Ą°a documented absolute CD4 T lymphocyte count of less than 300 cells per cubic millimeter or of less than 20% of total T cells on more than one occasion, no evidence of infection on HIV testing and the absence of any defined immunodeficiency or therapy associated with depressed levels of CD4 T cellsĄ±. The clinical course, immunologic characteristics, CD4 T cell kinetics, long term outcome and prognosis of this syndrome remain poorly defined but it is widely accepted that ICL is a rare, heterogeneous syndrome, usually detected after the occurrence of an opportunistic infection in a person without known immunodeficiency or immunodepression although it can also be an incidental laboratory finding. Autoimmune phenomena are common in this syndrome. In this article, we reported a case diagnosed with an EvansĄŻ syndrome and that fulfilled the CDCP definition of ICL.</Abstract>
</Article>
</ArticleSet>
